ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1098

Predialysis Venous Excess Ultrasound Grade Correlates with Cardiac and Pulmonary Congestion Rather Than Bioimpedance-Defined Fluid Overload in Patients on Hemodialysis

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Banda Lopez, Adriana, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jal., Mexico
  • Cruz Landino, Moises, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jal., Mexico
  • Garcia Vallejo, Diana Vianney, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jal., Mexico
  • Parra Guerra, Ricardo, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jal., Mexico
  • Rojas-Campos, Enrique, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jal., Mexico
  • Mendoza Cabrera, Salvador, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jal., Mexico
  • Piña Vicente, Brandon, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jal., Mexico
  • Ventura Cabrera, Carlos Ernesto, Instituto Mexicano del Seguro Social Delegacion Jalisco, Guadalajara, Jal., Mexico

Group or Team Name

  • Centro Médico Nacional de Occidente, IMSS
Background

Assessing volume status is critical in patients with End-Stage Kidney Disease (ESKD) on hemodialysis (HD) to achieve dry weight and minimize complications like intradialytic hypotension. While the Venous Excess Ultrasound (VExUS) score is increasingly used, evidence regarding its utility in guiding dynamic fluid removal and its correlation with other congestion markers remains limited. We hypothesized that predialysis VExUS findings would correlate more closely with cardiac and pulmonary congestion markers than with BCM-defined fluid overload.

Methods

This exploratory, single-center, observational study (October 2025) included 32 chronic HD patients presenting above their dry weight. We performed baseline echocardiography and Bioimpedance Spectroscopy (BCM). VExUS, Focused Cardiac Ultrasound (FOCUS), and Lung Ultrasound (LUS) were measured pre-HD, mid-HD, and post-HD.

Results

A total of 32 patients were included, of whom 8 (25%) had an anormal VEXUS score (1 grade 1, 1 grade 2 and 6 grade 3). There were no significant differences in baseline clinical characteristics or volumen-related between groups, including age, time on dialysis, comorbidities, predialysis weight,BCM defined fluid overload VExUS 0: 2.3kg, VExUS abnormal: 2.8kg-, total ultrafiltration (UF), pre- and post-HD blood pressure, interdialytic weight gain, or intradialytic hypotension events. However patients with abnormal VExUS findings exhibited greater LUS scores, and markers of impaired cardiac function, particularly RV dysfunction (p < 0.05). In patients with VExUS abnormal, scores improved during fluid removal without immediate rebound.
Significant correlations were found between VExUS and echocardiographic markers including RV S’ (ρ=-0.573, p=0.001), TAPSE (ρ=-0.396, p=0.025) and LVOT VTI (ρ=-0.408, p=0.020).

Conclusion

In this exploratory HD cohort, VExUS showed limited association with BCM-defined fluid overload but correlated with echocardiographic and pulmonary congestion markers, particularly indices of RV dysfunction. These findings suggest VExUS may reflect cardiorenal hemodynamic interaction rather than isolated intravascular volume excess. VExUS may therefore be most useful when integrated with clinical assessment, LUS, and focused echocardiography rather than an isolated ultrafiltration target.